Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bifeprunox Long-Term Safety and Efficacy in Schizophrenia
NCT00193687Phase 3Completed
- Sponsor
- Solvay
- Start
- Sep 2005
- Primary completion
- Jan 2008
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of bifeprunox in schizophrenia, sponsored by Solvay. Started Sep 2005; status: completed.
02
Drugs
bifeprunox
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00193687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00193687.